ATAIBECKLEY INC (ATAI) Stock Fundamental Analysis

NASDAQ:ATAI • US04650F1012

3.63 USD
-0.1 (-2.68%)
At close: Feb 27, 2026
3.67 USD
+0.04 (+1.1%)
After Hours: 2/27/2026, 8:00:02 PM
Fundamental Rating

3

ATAI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 193 industry peers in the Pharmaceuticals industry. No worries on liquidiy or solvency for ATAI as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, ATAI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year ATAI has reported negative net income.
  • ATAI had a negative operating cash flow in the past year.
  • ATAI had negative earnings in each of the past 5 years.
  • In the past 5 years ATAI always reported negative operating cash flow.
ATAI Yearly Net Income VS EBIT VS OCF VS FCFATAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

  • ATAI has a worse Return On Assets (-62.24%) than 65.80% of its industry peers.
  • ATAI has a Return On Equity of -93.44%. This is comparable to the rest of the industry: ATAI outperforms 40.41% of its industry peers.
Industry RankSector Rank
ROA -62.24%
ROE -93.44%
ROIC N/A
ROA(3y)-52.42%
ROA(5y)-70.02%
ROE(3y)-67.79%
ROE(5y)-86.99%
ROIC(3y)N/A
ROIC(5y)N/A
ATAI Yearly ROA, ROE, ROICATAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ATAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATAI Yearly Profit, Operating, Gross MarginsATAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -20K -40K -60K

7

2. Health

2.1 Basic Checks

  • ATAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ATAI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ATAI has more shares outstanding
  • Compared to 1 year ago, ATAI has a worse debt to assets ratio.
ATAI Yearly Shares OutstandingATAI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ATAI Yearly Total Debt VS Total AssetsATAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 4.32 indicates that ATAI is not in any danger for bankruptcy at the moment.
  • ATAI has a better Altman-Z score (4.32) than 72.02% of its industry peers.
  • There is no outstanding debt for ATAI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.32
ROIC/WACCN/A
WACC9.14%
ATAI Yearly LT Debt VS Equity VS FCFATAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

  • ATAI has a Current Ratio of 7.90. This indicates that ATAI is financially healthy and has no problem in meeting its short term obligations.
  • ATAI's Current ratio of 7.90 is fine compared to the rest of the industry. ATAI outperforms 74.09% of its industry peers.
  • A Quick Ratio of 7.90 indicates that ATAI has no problem at all paying its short term obligations.
  • The Quick ratio of ATAI (7.90) is better than 74.61% of its industry peers.
Industry RankSector Rank
Current Ratio 7.9
Quick Ratio 7.9
ATAI Yearly Current Assets VS Current LiabilitesATAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

  • The earnings per share for ATAI have decreased by 0.00% in the last year.
  • ATAI shows a decrease in Revenue. In the last year, the revenue decreased by -1.91%.
  • Measured over the past years, ATAI shows a very negative growth in Revenue. The Revenue has been decreasing by -75.28% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
Revenue 1Y (TTM)-1.91%
Revenue growth 3Y-75.28%
Revenue growth 5YN/A
Sales Q2Q%1772.5%

3.2 Future

  • Based on estimates for the next years, ATAI will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.21% on average per year.
  • ATAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 234.92% yearly.
EPS Next Y30.12%
EPS Next 2Y21%
EPS Next 3Y12.93%
EPS Next 5Y14.21%
Revenue Next Year475.51%
Revenue Next 2Y-44.62%
Revenue Next 3Y10.95%
Revenue Next 5Y234.92%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ATAI Yearly Revenue VS EstimatesATAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B
ATAI Yearly EPS VS EstimatesATAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 4

0

4. Valuation

4.1 Price/Earnings Ratio

  • ATAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ATAI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATAI Price Earnings VS Forward Price EarningsATAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATAI Per share dataATAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ATAI's earnings are expected to grow with 12.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21%
EPS Next 3Y12.93%

0

5. Dividend

5.1 Amount

  • No dividends for ATAI!.
Industry RankSector Rank
Dividend Yield 0%

ATAIBECKLEY INC

NASDAQ:ATAI (2/27/2026, 8:00:02 PM)

After market: 3.67 +0.04 (+1.1%)

3.63

-0.1 (-2.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12
Earnings (Next)03-16
Inst Owners12.45%
Inst Owner Change51.45%
Ins Owners3.7%
Ins Owner Change88.19%
Market Cap1.32B
Revenue(TTM)308.00K
Net Income(TTM)-149.27M
Analysts84.21
Price Target12.7 (249.86%)
Short Float %4.44%
Short Ratio4.21
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-74.59%
Min EPS beat(2)-131.54%
Max EPS beat(2)-17.64%
EPS beat(4)1
Avg EPS beat(4)-48.58%
Min EPS beat(4)-131.54%
Max EPS beat(4)17.15%
EPS beat(8)3
Avg EPS beat(8)-34.15%
EPS beat(12)6
Avg EPS beat(12)-5.69%
EPS beat(16)8
Avg EPS beat(16)-13.8%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.44%
PT rev (3m)2.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.44%
EPS NY rev (1m)2.85%
EPS NY rev (3m)-27.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-34.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)26.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4280.45
P/FCF N/A
P/OCF N/A
P/B 8.25
P/tB 8.43
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0
BVpS0.44
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -62.24%
ROE -93.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.42%
ROA(5y)-70.02%
ROE(3y)-67.79%
ROE(5y)-86.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1203.88%
Cap/Sales 3521.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.9
Quick Ratio 7.9
Altman-Z 4.32
F-Score4
WACC9.14%
ROIC/WACCN/A
Cap/Depr(3y)268.35%
Cap/Depr(5y)673.01%
Cap/Sales(3y)220.74%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
EPS Next Y30.12%
EPS Next 2Y21%
EPS Next 3Y12.93%
EPS Next 5Y14.21%
Revenue 1Y (TTM)-1.91%
Revenue growth 3Y-75.28%
Revenue growth 5YN/A
Sales Q2Q%1772.5%
Revenue Next Year475.51%
Revenue Next 2Y-44.62%
Revenue Next 3Y10.95%
Revenue Next 5Y234.92%
EBIT growth 1Y18.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-5.8%
EBIT Next 3Y-18.5%
EBIT Next 5Y-6.5%
FCF growth 1Y3.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.22%
OCF growth 3YN/A
OCF growth 5YN/A

ATAIBECKLEY INC / ATAI FAQ

What is the fundamental rating for ATAI stock?

ChartMill assigns a fundamental rating of 3 / 10 to ATAI.


Can you provide the valuation status for ATAIBECKLEY INC?

ChartMill assigns a valuation rating of 0 / 10 to ATAIBECKLEY INC (ATAI). This can be considered as Overvalued.


What is the profitability of ATAI stock?

ATAIBECKLEY INC (ATAI) has a profitability rating of 0 / 10.


What is the earnings growth outlook for ATAIBECKLEY INC?

The Earnings per Share (EPS) of ATAIBECKLEY INC (ATAI) is expected to grow by 30.12% in the next year.